Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDFSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.575.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDMSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.311SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.93SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.104SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.225SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.309SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.105SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.307SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.171SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.57SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.279SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.201SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
W.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.213SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.341SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.89SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.204SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.170SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.232SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.84SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.301SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.269SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.234SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Z.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
V.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used